AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

6P Response and survival according to the interferon-gamma (IFN-γ) signature and tumor mutational burden (tmb) in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma

Reijers, P. Dimitriadis, J.J. Traets, R. Saw, J.M. Versluis, T. Pennington, E. Kapiteijn,A.A.M. Van der Veldt, K. Suijkerbuijk, G. Hospers,W. Van Houdt, A. Broeks,S. Cornelissen, A. Spillane,R. Scolyer,B. van de Wiel, A.M. Menzies,A.C.J. van Akkooi,G.V. Long,C.U. Blank

Immuno-Oncology and Technology（2022）

引用 0|浏览4
暂无评分
关键词
neoadjuvant ipilimumab,interferon-gamma interferon-gamma,melanoma,tumor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要